Join Dr. Nadege Gunn, from the 2024 Liver Connect Conference. In this special episode, she is joined by Elizabeth Coacher, PA, and Ann Moore, FNP, to discuss the management of NASH (Nonalcoholic Steatohepatitis), newly approved treatments, and the importance of clinical trials.
They explore patient-centered care, lifestyle modifications, and non-invasive tests for identifying at-risk patients. Tune in for insights on balancing clinical trial participation with approved therapies, addressing patient access and equity, and the need for ongoing education in hepatology. This episode offers valuable information for healthcare providers committed to improving liver health. Don't miss this engaging and informative discussion!
Hosted by: Nadege Gunn, MD
With Special Guests: Elizabeth Goacher, PA, and Ann Moore, NP